IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
IOL Chemicals & Pharmaceuticals will hold an investor/analyst meet on May 29, 2026, from 10:00 AM to 5:00 PM. The management will interact with investors at the 360 ONE Capital 16th Annual Investor Conference in Mumbai.
May 22 2026 17:48:30
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
IOL Chemicals reported strong Q4 FY26 standalone results, with revenue rising 17.4% YoY to Rs.619.5 cr and net profit soaring 68.2% YoY to Rs.53.2 cr. The company also achieved its highest-ever quarterly revenue and a 15%+ EBITDA margin.
May 20 2026 18:37:35
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2026
IOL Chemicals & Pharmaceuticals reported strong Q4 FY26 consolidated results with revenue of ₹619.45 crore (up 17% YoY) and net profit of ₹53.16 crore (up 69% YoY). The board also approved a new Triacetin plant (6000 MTPA) and expanded Pantoprazole capacity (36 MTPA) with a total capex of ₹22.75 crore, funded internally for product portfolio diversification and demand growth.
May 20 2026 14:39:27
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
IOL Chemicals & Pharmaceuticals will organize an analyst/investor conference call on May 22, 2026, at 3:00 PM IST. The call is scheduled to discuss the company's financial performance for the quarter and year ended March 31, 2026, providing an opportunity for investors to engage with management.
May 18 2026 18:45:26
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Board Meeting Intimation for Notice Of The Board Meeting
IOL Chemicals' Board of Directors is scheduled to meet on May 20, 2026. The agenda includes considering and approving the company's audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
May 13 2026 16:34:43
Read More